About the Interactions Between Aging and Cancer Therapies Session
The interactions between aging and cancer therapies are complex and often result in altered responses to treatment. Older adults are more likely to experience intensified side effects from chemotherapy, radiation, or targeted therapies, partly due to changes in organ function, drug metabolism, and immune system efficacy. Additionally, age-related factors like cognitive decline and frailty can impact the patient’s ability to tolerate and adhere to treatment regimens. To optimize therapeutic outcomes, it is crucial to tailor cancer treatments for older patients, considering both the biological aspects of aging and the potential for drug interactions and toxicity.
Topics Covered in Interactions Between Aging and Cancer Therapies
Geriatric Assessment
Frailty Screening
Altered Drug Metabolism
Polypharmacy Risks
Chemotherapy Tolerance
Cognitive Decline
Related Scientific Sessions at CIOC 2027
Why Attend the Interactions Between Aging and Cancer Therapies Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Interactions Between Aging and Cancer Therapies work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Interactions Between Aging and Cancer Therapies research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Interactions Between Aging and Cancer Therapies track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Interactions Between Aging and Cancer Therapies Conference 2027 — FAQs
What is the Interactions Between Aging and Cancer Therapies track at CIOC 2027?
The Interactions Between Aging and Cancer Therapies track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Interactions Between Aging and Cancer Therapies. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Interactions Between Aging and Cancer Therapies sessions?
Cancer researchers and clinicians, educators and students with an interest in Interactions Between Aging and Cancer Therapies are all welcome — whether presenting or attending.
Can I present my research in the Interactions Between Aging and Cancer Therapies track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Interactions Between Aging and Cancer Therapies sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Interactions Between Aging and Cancer Therapies track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.